(VEVE) Vanguard FTSE Developed - Ratings and Ratios
Exchange: AS • Country: Netherlands • Currency: EUR • Type: Etf • ISIN: IE00BKX55T58 • Global Large-Cap Blend Equity
VEVE: Stocks, Bonds, Equities, Securities
The Vanguard FTSE Developed World UCITS ETF (AS:VEVE) is a well-structured investment vehicle designed for exposure to large-cap equities across developed markets globally. As a UCITS-compliant fund domiciled in Ireland, it offers the advantages of a regulated European framework, ensuring investor protection and cross-border distribution efficiency. This ETF is particularly appealing for its diversification benefits, covering a broad spectrum of companies in regions such as North America, Europe, and the Asia-Pacific, thereby mitigating concentration risk.
Tracking the Morningstar Global Target Market Exposure Net Return USD Index, the ETF employs a replication strategy, ensuring that investors gain exposure to a broad array of companies, including sector leaders and multinational corporations. This index is constructed to represent the performance of large-cap companies across developed markets, with a focus on market capitalization-weighted returns. The inclusion of a net return index means that it accounts for withholding taxes on dividends, providing a more accurate reflection of the returns an investor would experience. This approach is particularly beneficial for long-term investors seeking to capture the growth and stability typically associated with developed markets.
From a financial standpoint, the ETF boasts an asset base of approximately €3.5 billion, underscoring its liquidity and investor confidence. With a low expense ratio, it aligns with Vanguards tradition of cost-effective investment solutions, making it an attractive option for both individual and institutional investors. The ETFs focus on large-cap equities offers stability, while its broad diversification across various sectors ensures that no single industry dominates the portfolio, enhancing its resilience against market volatility. Additionally, the ETFs listing on the Euronext Amsterdam exchange (AS) provides European investors with easy access and efficient trading opportunities.
For fund managers and investors, the ETFs transparency and tracking efficiency are key attributes. The funds holdings are disclosed daily, allowing for precise tracking of its portfolio composition. This level of transparency, combined with its low tracking error, makes it a reliable tool for investors seeking to align their portfolios with the performance of developed markets. Moreover, its UCITS structure ensures compliance with stringent European regulations, providing an additional layer of security and operational reliability. This ETF is thus not only a cost-effective but also a prudent choice for constructing a diversified and resilient investment portfolio.
Additional Sources for VEVE ETF
VEVE ETF Overview
Market Cap in USD | 3,900m |
Category | Global Large-Cap Blend Equity |
TER | 0.12% |
IPO / Inception | 2014-09-30 |
VEVE ETF Ratings
Growth Rating | 71.1 |
Fundamental | - |
Dividend Rating | 54.6 |
Rel. Strength | -5.31 |
Analysts | - |
Fair Price Momentum | 85.28 EUR |
Fair Price DCF | - |
VEVE Dividends
Dividend Yield 12m | 1.65% |
Yield on Cost 5y | 3.08% |
Annual Growth 5y | 7.77% |
Payout Consistency | 89.9% |
VEVE Growth Ratios
Growth Correlation 3m | -88.4% |
Growth Correlation 12m | 54.5% |
Growth Correlation 5y | 90.2% |
CAGR 5y | 12.48% |
CAGR/Max DD 5y | 0.59 |
Sharpe Ratio 12m | 0.95 |
Alpha | -5.91 |
Beta | 0.737 |
Volatility | 32.55% |
Current Volume | 13.2k |
Average Volume 20d | 9.8k |
As of April 26, 2025, the stock is trading at EUR 91.50 with a total of 13,244 shares traded.
Over the past week, the price has changed by +4.27%, over one month by -8.28%, over three months by -11.69% and over the past year by +4.71%.
Yes. Based on ValueRay Analyses, Vanguard FTSE Developed (AS:VEVE) is currently (April 2025) a good stock to buy. It has a ValueRay Growth Rating of 71.06 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of VEVE as of April 2025 is 85.28. This means that VEVE is currently overvalued and has a potential downside of -6.8%.
Vanguard FTSE Developed has no consensus analysts rating.
According to ValueRays Forecast Model, VEVE Vanguard FTSE Developed will be worth about 95.5 in April 2026. The stock is currently trading at 91.50. This means that the stock has a potential upside of +4.42%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 95.5 | 4.4% |